Ann: Positive in vitro data for CHM 1301 CAR NK cells, page-72

I am hoping to see a turnaround of the chart as well.

Interestingly majority of the shares were held by the insiders but the SP has hit the wall around 4.7 cents on 3 different occasions.

Like IMU the first day of announcement the SP has had a lot of resistance then it got took off the next few days for a 300% ride. Hopefully this is also the case for CHM. Indeed the market cap is very low for what the potentials that this company's clinical trials has to offer, but we don't really want to go against the market either if that is how they sees the company potentials.